Exhibitor COVID-19 Resources

A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z

Disclaimer: The Exhibitor COVID-19 Resources page are commercial listings. Content and associated materials, including but not limited to resource descriptions, promotional messages and handouts are the sole responsibility of the commercial entity. AMP does not endorse any commercial product or service. AMP does not review the content of commercial activities. AMP makes no warranty, express or implied, regarding any commercial product or service, and hereby disclaims, the accuracy, completeness, timeliness or merchantability or fitness for a particular purpose of the COVID-19 resource content and associated materials. AMP shall not be liable for any damages, including direct, indirect, special, incidental, or consequential or any other type of damages arising out of or related to the use of the information contained in the COVID-19 resource listing or associated materials.


Click on a company's logo to visit their website for additional information.



Decoding the Immune Response to COVID-19

Adaptive Biotechnologies is a pioneer in immune-driven medicine aiming to improve lives by learning from the wisdom of the adaptive immune systems. Working with drug developers, clinicians and academic researchers, we apply these insights to develop products that will transform the way diseases are diagnosed and treated. Learn more:



Agilent Technologies

We offer a broad variety of high-quality workflow solutions for various research applications within genomics. Find everything you need to create your genomics workflow, from lab sample to library preparation, enrichment or hybridization, quality control, data analysis, interpretation, and reporting. Our team of application scientists with years of experience can help with your questions and share genomic knowledge with your laboratory.



Armored RNA Quant® SARS-CoV-2 Panel

We offer a broad variety of high-quality workflow solutions for various research applications within genomics. Find everything you need to create your genomics workflow, from lab sample to library preparation, enrichment or hybridization, quality control, data analysis, interpretation, and reporting. Our team of application scientists with years of experience can help with your questions and share genomic knowledge with your laboratory.

Asuragen has developed an Armored RNA control panel that targets the SARS-CoV-2 viral nucleocapsid (N), envelope (E), RNA-dependent RNA polymerase (RdRp), Open Reading Frame sequence (ORF1), and human RNase P regions. This panel aligns with the CDC and WHO recommended regions for testing providing a stable, and reliable way to rapidly test for the presence of the novel Coronavirus.



Novel Coronavirus Information Center

Elsevier’s free health and medical research on the novel coronavirus (SARS-CoV-2) and COVID-19.






COVID-19 Information for Providers

COVID-19 PCR and Antibody Test Information for Healthcare Providers.


Golden Helix

Genetic Analysis of the COVID-19 Virus and Other Pathogens

Next-Generation Sequencing technologies will allow us to gain a deeper understanding of this virus and develop advanced diagnostic capabilities to help patients and provide us the ability to conduct research at the same time. Download a free copy of this eBook to learn the different ways Golden Helix’s NGS solutions can deliver significant insights into this process.


Hologic Addresses Global Threat with Flexible Solutions

The emergence of SARS-CoV-2 was unforeseen, and the worldwide outbreak of COVID-19 has already impacted millions. In response to the desperate public need for rapid high-volume testing Hologic developed SARS-CoV-2 assays on both the Panther® and Panther Fusion systems®. Both assays will enable labs to run over 1000 tests in 24 hours and attain first results in 3.5 hours or less.



SARS-CoV-2 research reagents from IDT

Explore SARS-CoV-2 research reagents from IDT, whether your project includes qPCR, CRISPR-Cas13, or NGS components. Our distributed manufacturing capabilities and clean facilities are uniquely suited to rapid, accurate production of contaminant-free elements essential to SARS-CoV-2 detection as well as COVID-19 therapeutic and epidemiological studies. Both stocked and custom products are available now.



Invivoscribe Launches COVID-19 Diagnostic Testing with Option to Participate in SARS-CoV-2 Antibody and Vaccine Program

Invivoscribe, Inc., a global leader in precision diagnostics is offering COVID-19 testing through their CLIA/CAP, NY State Licensed LabPMM reference laboratory in San Diego, CA. The test can be ordered by healthcare providers for patients suspected of having COVID-19. Tested subjects can choose to enroll in an ongoing research study designed to accelerate identification of promising antibody and vaccine candidates.



Meeting your demands for scalable SARS-CoV-2 detection

LGC, Biosearch Techologies enables rapid, large-scale implementation of laboratory diagnostics for COVID-19 by expediting availability of mission-critical extraction chemistries, oligos, RT-PCR/PCR reagents, quality control solutions, and instrumentation that deliver 2019 Novel Coronavirus detection at scale.





Flexible Testing Options for SARS-CoV-2

In response to the global outbreak of the novel coronavirus disease (COVID-19), Luminex has developed multiple solutions to enhance our NxTAG® and ARIES® offerings in order to automate and facilitate the detection of coronavirus.



Multi-Omic COVID-19 Research Tools from NanoString

The COVID-19 Panel Plus assay can be added to any nCounter® gene expression panel or Custom CodeSet, enabling measurement of SARs-CoV-2 & the human or mouse ACE2 receptor as well as the measurement of the host response. The GeoMx® Digital Spatial Profiler enables simultaneous, high-plex, spatial analysis of pathogenesis and the host response within FFPE & fresh frozen tissue sections.



New England Biolabs: Supporting COVID-19 Research

NEB offers a range of products to support COVID-19 applications, including RNA extraction, virus detection, sequencing and epidemiology, and vaccine development. We are committed to supplying and supporting customers with reagents they need to validate and develop them as diagnostic tools for lab-based or point-of-care settings. Please visit our COVID-19 page for the latest information, including products, relevant preprints, and application notes.


Ovation COVID-19 testing and resources webpage

Ovation has launched COVID-19 testing capabilities, allowing our labs to support getting ahead of this pandemic. Our microsite shows our capabilities, and has CDC and FDA updates linked as well.




Paragon Genomics

CleanPlex SARS-COV-2 Targeted Sequencing Assay Application Page

The application page highlights Paragon Genomics' amplicon-based target enrichment assay for SARS-COV-2 detection and sequencing by NGS. The page showcases the CleanPlex assay’s high sensitivity and high coverage with minimal sequencing depth, to enable effective COVID-19 tracking and surveillance. Also available are technical notes, publications using the CleanPlex SARS-COV-2 Panel, and our webinar presenting data on clinical patient samples.


PCR Biosystems

RT-qPCR Reagents for SARS-CoV-2 Detection and Research

PCR Biosystems is committed to providing researchers, developers and diagnostic kit manufacturers with the PCR products and support needed in the global response to COVID-19. Discover our recommended products for accurate and sensitive detection of the SARS-CoV-2 virus, including 2x and 4x probe-based 1-step RT-qPCR kits manufactured under our rigorous ISO 13485:2016 quality system.




PerkinElmer is working closely with pathology laboratories around the world to deliver the nucleic acid isolation, automation, real-time PCR, antibody testing, and NGS library preparation solutions they need to rapidly respond to the SARS-CoV-2 challenges both today and tomorrow. With flexible, single-source workflows, PerkinElmer is here to provide the technology and support you need.




Promega Resources for Coronavirus Testing & Research

Promega Corporation provides innovative solutions and technical support for scientists performing molecular and immunological assays. Our technology portfolio includes products for cell biology; DNA, RNA and protein analysis; drug development, and molecular diagnostics used for coronavirus testing and research. We offer custom manufacturing services designed to adapt Promega product or technologies to your specific needs.


Q2 Solutions Laboratory Solutions to Support Global COVID-19 Clinical Trials

Our global network of state-of-the-art laboratories offer Central Laboratories located in the United States, United Kingdom, India, Singapore, China, and Japan, with partner laboratories in South America and South Africa. Our Centers of Excellence for Vaccines, Genomics and Bioanalytical/ADME are strategically located to offer worldwide testing solutions.


SmartGene Software Solutions for Sequencing Coronavirus

SmartGene is an established bioinformatics application service provider (ASP), delivering secure, integrated, software solutions, for the management and analysis of sequencing data, including for Coronavirus. Our specific applications enable rapid identification, genotyping and analysis of pathogens, for clinical diagnostics, clinical research, epidemiological surveillance and industrial purposes. SmartGene’s Modules address Coronavirus, HIV, HCV, Influenza, Bacteria, Fungi and Microbiomes.



Sunquest delivers rapid response solutions to help labs manage COVID-19 testing, including molecular LIMS

Sunquest recognizes the impact COVID-19 has had on our customers, employees and partners, and is doing our part to deliver service, product, compassion and care to those working tirelessly every day to protect the community. Check out what Sunquest has available today to help support healthcare organizations with managing the demands associated with the COVID-19 outbreak:

Vela Diagnostics

The ViroKey™ SARS-CoV-2 RT-PCR Test by Vela Diagnostics

The ViroKey™ SARS-CoV-2 RT-PCR Test by Vela Diagnostics is a probe-based reverse transcription PCR test that detects the virus by targeting conserved regions of the SARS-CoV-2 genome, and can be used on automated and manual workflows.


COVID-19 Laboratory Resource Center

During these turbulent times, COVID-19 information is changing quickly. XIFIN is committed to helping laboratories and diagnostics providers obtain the information they need, including the latest on testing, testing supply needs, and payor billing requirements.

Zymo Research

Zymo Research’s approved end-to-end COVID-19 testing technologies

Zymo Research is a California-based biotech company that provides end-to-end solutions used in multiple FDA EUA authorized COVID-19 tests. The company provides solutions for sample collection and transport that allow for ambient temperature shipping and viral inactivation, high-throughput automated sample processing, and an extremely high-sensitive real-time RT-PCR SARS-CoV-2 molecular diagnostic test. Learn more about our COVID-19 efforts through link below..


Corporate Partners